SPLEEN TO SCREEN
Live / Registered — Registered (as of 13 Aug 2019)
What this means for you
Registered since 13 Aug 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79227419
- Registration number
- 5830546
- Mark type
- Stylized text
- Filed
- 21 Jul 2017
- Published for opposition
- 28 May 2019
- Registered
- 13 Aug 2019
- Attorney of record
- Brent Routman
Goods and services
- Class 001 — Chemicals: Biochemical products used in the medical and pharmaceutical industry and in science, in particular antibodies in the nature of protein mixtures for rapidly screening panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations prepared with antibodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science for the treatment of cancer and other therapeutic indications, namely, for the generation of mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases
- Class 042 — Scientific and technological services: Services of biochemists, namely, scientific and medical laboratory services in the nature of efficient screening of antibodies in the nature of protein mixtures for the generation of mono and multispecific biologics; services of bacteriologic and biochemical laboratories, namely, research in the field of biochemistry; professional advice relating to biochemistry; conducting scientific and industrial research using laboratory techniques, namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and preparing related professional reports; professional advice relating to scientific and industrial research using laboratory techniques, namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; reviewing and analyzing anti-bodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science and the preparation of related professional reports for scientists, engineers, analysts and laboratory assistants and technicians for industry and government services; scientific and industrial research, in particular in the field of the aforementioned anti-bodies, namely, anti-bodies in the nature of protein mixtures; research and development of new products for others, in particular anti-bodies in the nature of protein mixtures; chemical and laboratory research services, namely, performing extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; consultancy relating to chemical and laboratory research services, namely, the performance of extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports
- Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; genetic testing of research animals, in particular of transgenic mice for research purposes
- Class 045 — Legal and security services: Legal services; legal services relating to exploitation of intellectual property rights; licensing of intellectual property rights; legal advisory services in the aforementioned fields, namely, exploitation of intellection property rights and licensing of intellectual property rights, concerning rapid screening of panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics in the fields of immuno-oncology and auto-immune diseases
Owner
- Merus B.V., NL
- Merus N.V., NL
- Merus N.V., NL
- Merus N.V., NL
Prosecution history
- 19 Mar 2026 — CHANGE OF OWNER RECEIVED FROM IB
- 13 Feb 2026 — TEAS SECTION 71 & 15 RECEIVED
- 09 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Feb 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 09 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Aug 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 30 Jul 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jul 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 30 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Dec 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB